ibandronate [Bondronat]

DRUG4 trials

Sponsors

Hoffmann-La Roche

Conditions

Bone NeoplasmNeoplasm MetastasisPainPain; Bone Neoplasms; Neoplasm Metastasis

Phase 2

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

WithdrawnNCT00478270

Hoffmann-La RocheBone Neoplasm, Neoplasm Metastasis, Pain

Start: 2007-06-30End: 2008-02-29Updated: 2017-08-16

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

CompletedNCT00502736

Hoffmann-La RochePain; Bone Neoplasms; Neoplasm Metastasis

Start: 2008-01-31End: 2009-03-31Updated: 2014-01-22

Phase 3

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

TerminatedNCT00099203

Hoffmann-La RocheBone Neoplasm, Neoplasm Metastasis, Pain

Start: 2005-07-31End: 2007-12-31Updated: 2017-08-16

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

TerminatedNCT00099177

Hoffmann-La RocheBone Neoplasm, Neoplasm Metastasis, Pain

Start: 2005-08-31End: 2007-12-31Updated: 2017-08-16